Valentin David
Overview
Explore the profile of Valentin David including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
65
Citations
2647
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Tiwari R, Sharma R, Rajendran G, Borkowski G, An S, Schonfeld M, et al.
J Clin Invest
. 2024 Dec;
135(3).
PMID: 39621585
Ischemic acute kidney injury (AKI) is common in hospitalized patients and increases the risk for chronic kidney disease (CKD). Impaired endothelial cell (EC) functions are thought to contribute in AKI...
2.
Donnan M, Deb D, Dalal V, David V, Procissi D, Quaggin S
Arterioscler Thromb Vasc Biol
. 2024 Nov;
45(1):104-112.
PMID: 39540281
Background: Lymphangiogenesis is believed to be a protective response in the setting of multiple forms of kidney injury and mitigates the progression of interstitial fibrosis. To augment this protective response,...
3.
Courbon G, David V
Curr Opin Nephrol Hypertens
. 2024 Apr;
33(4):368-374.
PMID: 38661434
Purpose Of Review: Iron deficiency regulates the production of the bone-derived phosphaturic hormone fibroblast growth factor 23 (FGF23) but also its cleavage, to generate both intact (iFGF23) and C-terminal (Cter)-FGF23...
4.
Courbon G, Kentrup D, Thomas J, Wang X, Tsai H, Spindler J, et al.
JCI Insight
. 2023 Nov;
8(24).
PMID: 37943605
Fibroblast growth factor 23 (FGF23) is a phosphate-regulating (Pi-regulating) hormone produced by bone. Hereditary hypophosphatemic disorders are associated with FGF23 excess, impaired skeletal growth, and osteomalacia. Blocking FGF23 became an...
5.
Tiwari R, Sharma R, Rajendran G, Borkowski G, An S, Schonfeld M, et al.
bioRxiv
. 2023 Oct;
PMID: 37873349
Ischemic acute kidney injury (AKI) is common in hospitalized patients and increases the risk for chronic kidney disease (CKD). Impaired endothelial cell (EC) functions are thought to contribute in AKI...
6.
David V, Salusky I, Malluche H, Nickolas T
Curr Opin Nephrol Hypertens
. 2023 Sep;
32(6):559-564.
PMID: 37753646
Purpose Of Review: Renal osteodystrophy (ROD) is a complex disorder of bone metabolism that affects virtually all adults and children with chronic kidney disease (CKD). ROD is associated with adverse...
7.
Donnan M, Deb D, David V, Quaggin S
bioRxiv
. 2023 May;
PMID: 37205366
Background: Lymphangiogenesis is believed to be a protective response in the setting of multiple forms of kidney injury and mitigates the progression of interstitial fibrosis. To augment this protective response,...
8.
Martinez-Calle M, Courbon G, Hunt-Tobey B, Francis C, Spindler J, Wang X, et al.
J Clin Invest
. 2023 Apr;
133(11).
PMID: 37079387
Renal osteodystrophy (ROD) is a disorder of bone metabolism that affects virtually all patients with chronic kidney disease (CKD) and is associated with adverse clinical outcomes including fractures, cardiovascular events,...
9.
Courbon G, Thomas J, Martinez-Calle M, Wang X, Spindler J, Von Drasek J, et al.
Blood
. 2023 Apr;
142(1):106-118.
PMID: 37053547
Inflammation leads to functional iron deficiency by increasing the expression of the hepatic iron regulatory peptide hepcidin. Inflammation also stimulates fibroblast growth factor 23 (FGF23) production by increasing both Fgf23...
10.
Lima F, Monier-Faugere M, Mawad H, David V, Malluche H
Clin Nephrol
. 2023 Mar;
99(5):209-218.
PMID: 36970967
Aims: Renal osteodystrophy occurs in the early stages of chronic kidney disease (CKD) and progresses during loss of kidney function. Fibroblast growth factor (FGF)-23 and sclerostin, both produced by osteocytes,...